 |
PDBsum entry 4j2k
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase inhibitor
|
PDB id
|
|
|
|
4j2k
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Plos One
8:e62252
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of a plant trypsin inhibitor from Enterolobium contortisiliquum (EcTI) and of its complex with bovine trypsin.
|
|
D.Zhou,
Y.A.Lobo,
I.F.Batista,
R.Marques-Porto,
A.Gustchina,
M.L.Oliva,
A.Wlodawer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A serine protease inhibitor from Enterolobium contortisiliquum (EcTI) belongs to
the Kunitz family of plant inhibitors, common in plant seeds. It was shown that
EcTI inhibits the invasion of gastric cancer cells through alterations in
integrin-dependent cell signaling pathway. We determined high-resolution crystal
structures of free EcTI (at 1.75 Å) and complexed with bovine trypsin (at 2
Å). High quality of the resulting electron density maps and the redundancy of
structural information indicated that the sequence of the crystallized isoform
contained 176 residues and differed from the one published previously. The
structure of the complex confirmed the standard inhibitory mechanism in which
the reactive loop of the inhibitor is docked into trypsin active site with the
side chains of Arg64 and Ile65 occupying the S1 and S1' pockets, respectively.
The overall conformation of the reactive loop undergoes only minor adjustments
upon binding to trypsin. Larger deviations are seen in the vicinity of Arg64,
driven by the needs to satisfy specificity requirements. A comparison of the
EcTI-trypsin complex with the complexes of related Kunitz inhibitors has shown
that rigid body rotation of the inhibitors by as much as 15° is required for
accurate juxtaposition of the reactive loop with the active site while
preserving its conformation. Modeling of the putative complexes of EcTI with
several serine proteases and a comparison with equivalent models for other
Kunitz inhibitors elucidated the structural basis for the fine differences in
their specificity, providing tools that might allow modification of their
potency towards the individual enzymes.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |